FDA Inspection 1081592 — Albemarle US, Inc.

Albemarle US, Inc. — FEI 1032207

The FDA completed an inspection of Albemarle US, Inc. on January 25, 2019 in Kings Mountain, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 25, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Kings Mountain, NC (United States)